Cat# : SLT-414
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| SLT-414 | CoronaVac | April 27, 2024 | 1 vial | $998.00 |
|
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | SLT-414 |
| Product Name: | CoronaVac |
| Description: | CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation2. It was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it with B-propiolactone1,2. In preclinical trials, PiCoVacc induced SARS-CoV-2-specific neutralizing antibodies in rats, mice, and the rhesus macaque. The antibodies were found to neutralize 10 representative SARS-CoV-2 strains. As of August 2020, the vaccine is being tested in numerous human clinical trials assessing its safety and immunogenicity. |
| Biologic Classification: | Vaccines Inactivated |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
